BioCheck

BioCheck Develops and Manufactures High-Quality Enzyme Immunoassay Kits for the Global Biomedical, Pharmaceutical, and Scientific Research MarketsWith over four years of experience from its founder, BioCheck is able to quickly provide reliable products to its customers. Each BioCheck EIA kit is manufactured in compliance with U.S. Food and Drug Administration (FDA) Good Manufacturing Practices and ISO standards. Currently, the company produces more than 40 EIA test kits, 17 of which have received FDA approval, and these kits are distributed worldwide. BioCheck is also a leading developer of immunodiagnostic products, with extensive experience in bringing new IVD products to market, now including the development of ultra-sensitive Simoa™ assays (Single Molecule Array) and diagnostic test kits on the MS-Fast chemiluminescence platform. BioCheck is currently commercializing the MS-FAST analyzer (an automated chemiluminescence immunoassay system) and associated COVID-19 test kits, enabling convenient, rapid, and accurate disease diagnosis using benchtop instrumentation.